Levetiracetam Injection
Product Images NDC 65219-044

This text provides information about a study comparing the effects of Levetiracetam at doses of 1000 mg/day and 3000 mg/day with a placebo on an unspecified parameter. The study found statistically significant results compared to the placebo group.*

This text provides percentages and information related to the comparison of Levetiracetam doses with a placebo in a study involving patients. The percentages mentioned are 4%, 40%, 35.2%, 35%, 30%, 20.8%, 20%, 15%, 6.3%, and 5%. The study compares the effectiveness of Levetiracetam at doses of 1000 mg/day and 2000 mg/day with a placebo based on statistical significance.*

This text provides information about the percentage values for different groups (100%, 72.2%, 50%, 45.2%) and mentions a comparison between a placebo group (N=84) and a group taking Levetiracetam (N=79), indicating that the results were statistically significant versus placebo.*

This text describes a medication called Levetiracetam in 0.82% Sodium Chloride Injection, with a concentration of 500 mg in 100 mL. It is for intravenous infusion only and should be used immediately once removed from the overwrap and infused over a 15-minute period. The solution includes Levetiracetam, Sodium Chloride, Glacial Acetic Acid, and is buffered at pH 5.5. The product should not be further diluted, and should only be used if the solution is clear. The usual adult dosage is indicated in the package insert. The medication should be stored at 20° to 25°C, and is contained in a single-dose dual port bag.Unused portions should be discarded, and the closure is not made with natural rubber latex. The manufacturer is Fresenius Kabi, located in Lake Zurich, IL, producing non-PVC, Non-DEHP products.*

This is a description of Levetiracetam, a medication available in 500 mg strength in 100 mL bags of 0.82% Sodium Chloride Injection, with a concentration of 5 mg per mL. It is for Intravenous Infusion Only and should be stored at 20°C to 25°C. The medication is packaged in 24 x 100 mL Single-Dose Bags. The manufacturer is FRESENIUS KABI, located in Lake Zurich, IL 60047, and the product is made in Norway. The expiration date format is YYYY-MM, and caution is advised to check for leaks before use.*

This text provides information about Levetiracetam in 0.75% Sodium Chloride Injection, with a concentration of 1,000 mg in 100 mL (10 mg per mL) for intravenous infusion only. It specifies to use immediately once removed from overwrap and to infuse it over a period of 15 minutes. The solution also contains Sodium Chloride, Glacial Acetic Acid, and is buffered at pH 5.5. It warns not to use in series connections, not to dilute it further before use, and to only use if the solution is clear. The usual adult dosage is indicated in the package insert. It is recommended to store between 20° to 25°C and discard any unused portion. The container closure is not made with natural rubber latex and is non-PVC, non-DEHP. The product is manufactured for Fresenius Kabi in Lake Zurich, IL.*

This text provides information about a medication with the NDC code 65219-044-71, which is Levetiracetam in 0.75% Sodium Chloride Injection, with 1,000 mg in 100 mL (10 mg per mL) concentration. It is available in a packaging of 24 x 100 mL Single-Dose Bags. The medication is intended for intravenous infusion and should be stored at 20°C to 25°C (68°F to 77°F). The manufacturing information indicates that the product is made in Norway for Fresenius Kabi in Lake Zurich, IL. The text also contains instructions on how to check for leaks and mentions the expiration date format as YYYY-MM.*

The text describes a medication called Levetiracetam in 0.54% Sodium Chloride Injection. Each 100 mL contains 1,500 mg of Levetiracetam to be infused over 15 minutes. It's important to use it immediately after removing it from the overwrap and ensure that the solution is clear before use. The product is not to be further diluted or used in series connections. The usual adult dosage should be referenced in the package insert. The medication should be stored at 20°C to 25°C. The container is single-dose and the closure does not contain natural rubber latex or DEHP. The medication is manufactured by Fresenius Kabi.*

This text provides information about Levetiracetam, a medication contained in 0.54% Sodium Chloride Injection. Each bag holds 1,500 mg in 100 mL, equivalent to 15 mg per mL. The product is for intravenous infusion only and comes in a package of 24 x 100 mL single-dose bags. Storage instructions range from 20°C to 25°C (68°F to 77°F), with reference to USP Controlled Room Temperature guidelines. The manufacturing details indicate it is made for Fresenius Kabi in Lake Zurich, IL, with origin in Norway. The label includes lot number, expiration date, and a cautionary note about checking for leaks before use.*